Command Palette

Search for a command to run...

NATHBIOGEN

196.09-1.07 (-0.54%)

Quarterly ResultsProfit & LossBalance SheetCash Flow

Key Insights

POSITIVE
  • Recent quarter shows a significant improvement in net profit compared to lower prior quarters.
  • Despite increased expenditures, the previous quarter had positive operating margins indicating operational efficiency.
  • Latest net sales peaked significantly compared to previous quarters, reflecting strong market demand.
NEGATIVE
  • Company experienced a cash flow shortfall with a 10% decrease this year [Dummy Data]
  • Company’s strategic partnerships have yet to generate expected growth. [Dummy Data]
  • Company’s EBITDA shrank at a CAGR of -8% over the past 3 years. [Dummy Data]
Quarterly Results Data
FieldTrendSep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25
Revenue
22.5731.7443.04243.8832.1936.8751.97283.70
Expenses
20.2529.6941.16210.4131.1833.5654.26249.59
Operating Profit
2.322.051.8733.471.013.31-2.2934.11
Other Income
0.060.040.410.130.080.483.861.76
Interest
2.442.841.072.242.983.901.373.20
Depreciation
0.760.760.980.820.820.821.340.97
Profit Before Tax
2.384.592.2933.601.093.791.5735.88
Tax
0.350.770.610.25-0.031.140.630.66
Net Profit
2.033.822.6233.361.112.651.4837.28
EPS in Rs
0.862.021.8717.490.531.331.1419.58